MARK2 Gene

Name MAP/microtubule affinity-regulating kinase 2
Description This gene encodes a member of the Par-1 family of serine/threonine protein kinases. The protein is an important regulator of cell polarity in epithelial and neuronal cells, and also controls the stability of microtubules through phosphorylation and inactivation of several microtubule-associating proteins. The protein localizes to cell membranes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMARK2, also known as Par1b, plays a crucial role in neuronal function and microtubule regulation. It phosphorylates tau protein at specific serine residues within critical motifs, thereby reducing tau’s affinity for microtubules—a process central to the regulation of microtubule dynamics and implicated in Alzheimer’s neurofibrillary pathology. Structural studies have revealed details of its catalytic and ubiquitin‐associated domains, and functional investigations further demonstrate that MARK2 phosphorylates proteins such as the kinesin family member GAKIN/KIF13B, which is essential for axon formation and proper neuronal cargo transport. Collectively, these studies highlight MARK2’s pivotal function in establishing and maintaining neuronal polarity and cytoskeletal architecture."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its neuronal roles, MARK2 is a master regulator of cell polarity and cytoskeletal organization. It phosphorylates diverse substrates—from class IIa histone deacetylases to RhoA regulators like GEF‐H1—to modulate actin dynamics and microtubule stability. In response to specific extracellular signals, such as Rac1 activation and even bacterial challenge (e.g. Helicobacter pylori infection), MARK2 redistributes from the cytosol to the plasma membrane to coordinate changes in epithelial junctions and intracellular organization. Its activity is equally important during mitosis; by controlling microtubule growth and spindle centering, MARK2 ensures the proper orientation of the mitotic spindle, which is vital for accurate cell division and the maintenance of tissue architecture. Its interactions with proteins critical for cell–cell as well as cell–matrix adhesion (for example, via utrophin complexes) further underscore its central role in integrating cytoskeletal cues."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDysregulation of MARK2 is linked to diverse pathological conditions, including cancer, neurodegeneration, and infectious diseases. Its abnormal expression or posttranslational modifications contribute to melanoma progression and chemoresistance in lung and breast cancers by modulating metabolic pathways—such as stimulating the mTOR/HIF-1α axis while repressing p53-dependent transcription. In infectious contexts, pathogens like Helicobacter pylori and HIV-1 manipulate MARK2 signaling to disrupt cellular junctions and facilitate viral trafficking. Furthermore, MARK2 functions in the cellular stress response by phosphorylating eIF2α and establishing reciprocal regulatory loops with acetyltransferases (e.g. CREB-binding protein), processes that have direct relevance to proteotoxic stress and tau pathology seen in neurodegeneration. Finally, changes in MARK2 splicing have been associated with altered cellular phenotypes in renal allograft pathology, underscoring the broad impact of MARK2 signaling on human disease."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shinichi Kosuga, Etsu Tashiro, Toshifumi Kajioka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GSK-3beta directly phosphorylates and activates MARK2/PAR-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M507941200"}], "href": "https://doi.org/10.1074/jbc.M507941200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16257959"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16257959"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Saravanan Panneerselvam, Alexander Marx, Eva-Maria Mandelkow, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Structure (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.str.2005.09.022"}], "href": "https://doi.org/10.1016/j.str.2005.09.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16472737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16472737"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ji-Wu Wang, Yuzuru Imai, Bingwei Lu "}, {"type": "b", "children": [{"type": "t", "text": "Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.5094-06.2007"}], "href": "https://doi.org/10.1523/JNEUROSCI.5094-06.2007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17234589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17234589"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Yuta Yoshimura, Takeshi Terabayashi, Hiroaki Miki "}, {"type": "b", "children": [{"type": "t", "text": "Par1b/MARK2 phosphorylates kinesin-like motor protein GAKIN/KIF13B to regulate axon formation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01181-09"}], "href": "https://doi.org/10.1128/MCB.01181-09"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20194617"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20194617"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Martin Schwalbe, Jacek Biernat, Stefan Bibow, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation of human Tau protein by microtubule affinity-regulating kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi401266n"}], "href": "https://doi.org/10.1021/bi401266n"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24251416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24251416"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yue Han, Min Li, Bingqing Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARK2 phosphorylates KIF13A at a 14-3-3 binding site to polarize vesicular transport of transferrin receptor within dendrites."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2316266121"}], "href": "https://doi.org/10.1073/pnas.2316266121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38709923"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38709923"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Franck Dequiedt, Maud Martin, Julia Von Blume, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00231-06"}], "href": "https://doi.org/10.1128/MCB.00231-06"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16980613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16980613"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Zaher Zeaiter, David Cohen, Anne Müsch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Microbiol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1462-5822.2007.01084.x"}], "href": "https://doi.org/10.1111/j.1462-5822.2007.01084.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18005242"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18005242"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Zuzana Motovska, Petr Widimsky, Jan Kvasnicka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Coagul Fibrinolysis (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/mbc.0b013e328325455b"}], "href": "https://doi.org/10.1097/mbc.0b013e328325455b"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19530321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19530321"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Joseph Lin, Kirk K Hou, Helen Piwnica-Worms, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The polarity protein Par1b/EMK/MARK2 regulates T cell receptor-induced microtubule-organizing center polarization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0803887"}], "href": "https://doi.org/10.4049/jimmunol.0803887"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19553522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19553522"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Kazunari Yamashita, Atsushi Suzuki, Yoshinori Satoh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2009.11.144"}], "href": "https://doi.org/10.1016/j.bbrc.2009.11.144"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19945424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19945424"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Dorthe Matenia, Cindy Hempp, Thomas Timm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microtubule affinity-regulating kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: effects on mitochondrial transport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.262287"}], "href": "https://doi.org/10.1074/jbc.M111.262287"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22238344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22238344"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yukako Nishimura, Kathryn Applegate, Michael W Davidson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Automated screening of microtubule growth dynamics identifies MARK2 as a regulator of leading edge microtubules downstream of Rac1 in migrating cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0041413"}], "href": "https://doi.org/10.1371/journal.pone.0041413"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22848487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22848487"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Katherine T Lewandowski, Helen Piwnica-Worms "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation of the E3 ubiquitin ligase RNF41 by the kinase Par-1b is required for epithelial cell polarity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.129148"}], "href": "https://doi.org/10.1242/jcs.129148"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24259665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24259665"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Roland Hubaux, Kelsie L Thu, Emily A Vucic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.29577"}], "href": "https://doi.org/10.1002/ijc.29577"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25907283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25907283"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Madeleine Hart, Ihsan Zulkipli, Roshan Lal Shrestha, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARK2/Par1b kinase present at centrosomes and retraction fibres corrects spindle off-centring induced by actin disassembly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Open Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1098/rsob.180263"}], "href": "https://doi.org/10.1098/rsob.180263"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31238822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31238822"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Anastasia Mashukova, Radia Forteza, Viraj N Shah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The cell polarity kinase Par1b/MARK2 activation selects specific NF-kB transcripts via phosphorylation of core mediator Med17/TRAP80."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1091/mbc.E20-10-0646"}], "href": "https://doi.org/10.1091/mbc.E20-10-0646"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33596087"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33596087"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Miguel Hueso, Violeta Beltran, Francesc Moreso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Splicing alterations in human renal allografts: detection of a new splice variant of protein kinase Par1/Emk1 whose expression is associated with an increase of inflammation in protocol biopsies of transplanted patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2004.01.008"}], "href": "https://doi.org/10.1016/j.bbadis.2004.01.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15158914"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15158914"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Parul Hazarika, Marya F McCarty, Victor G Prieto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-04-0823"}], "href": "https://doi.org/10.1158/0008-5472.CAN-04-0823"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15492257"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15492257"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hiroko Nishikawa, Takeru Hayashi, Fumio Arisaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impact of structural polymorphism for the Helicobacter pylori CagA oncoprotein on binding to polarity-regulating kinase PAR1b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep30031"}], "href": "https://doi.org/10.1038/srep30031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27445265"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27445265"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Scott M Thompson, Jin Wang, Vishal S Chandan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Magn Reson Imaging (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mri.2016.11.005"}], "href": "https://doi.org/10.1016/j.mri.2016.11.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27845245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27845245"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Viacheslav Malikov, Mojgan H Naghavi "}, {"type": "b", "children": [{"type": "t", "text": "Localized Phosphorylation of a Kinesin-1 Adaptor by a Capsid-Associated Kinase Regulates HIV-1 Motility and Uncoating."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2017.08.076"}], "href": "https://doi.org/10.1016/j.celrep.2017.08.076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28930676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28930676"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ihsan Zulkipli, Joanna Clark, Madeleine Hart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spindle rotation in human cells is reliant on a MARK2-mediated equatorial spindle-centering mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201804166"}], "href": "https://doi.org/10.1083/jcb.201804166"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29941476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29941476"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yu-Ning Lu, Sarah Kavianpour, Tao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MARK2 phosphorylates eIF2α in response to proteotoxic stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pbio.3001096"}], "href": "https://doi.org/10.1371/journal.pbio.3001096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33705388"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33705388"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Shunyu Hou, Xiaoqian Zhang, Jian Yang "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2021.112929"}], "href": "https://doi.org/10.1016/j.yexcr.2021.112929"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34793775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34793775"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Lavanya Ponnusamy, Sathan Raj Natarajan, Ravi Manoharan "}, {"type": "b", "children": [{"type": "t", "text": "MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.30219"}], "href": "https://doi.org/10.1002/jcb.30219"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35048405"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35048405"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Zarin Tabassum, Jui-Heng Tseng, Camryn Isemann, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2022.101977"}], "href": "https://doi.org/10.1016/j.jbc.2022.101977"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35469920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35469920"}]}]}]}
Synonyms PAR-1, EMK1, PAR1B, PAR-1B, EMK-1
Proteins MARK2_HUMAN
NCBI Gene ID 2011
API
Download Associations
Predicted Functions View MARK2's ARCHS4 Predicted Functions.
Co-expressed Genes View MARK2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MARK2's ARCHS4 Predicted Functions.

Functional Associations

MARK2 has 9,972 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 130 datasets.

Click the + buttons to view associations for MARK2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of MARK2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of MARK2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MARK2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of MARK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of MARK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of MARK2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of MARK2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of MARK2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of MARK2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of MARK2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MARK2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of MARK2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Gene Mutation Profiles cell lines with MARK2 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with MARK2 protein from the CCLE Cell Line Proteomics dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MARK2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MARK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of MARK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MARK2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing MARK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing MARK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with MARK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with MARK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
CORUM Protein Complexes protein complexs containing MARK2 protein from the CORUM Protein Complexes dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MARK2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with MARK2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with MARK2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with MARK2 gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of MARK2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by MARK2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with MARK2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with MARK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with MARK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with MARK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with MARK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MARK2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MARK2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MARK2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing MARK2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with MARK2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with MARK2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of MARK2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MARK2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MARK2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of MARK2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MARK2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of MARK2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MARK2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of MARK2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of MARK2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving MARK2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving MARK2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving MARK2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing MARK2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing MARK2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing MARK2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by MARK2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by MARK2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by MARK2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MARK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of MARK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MARK2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with MARK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with MARK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with MARK2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with MARK2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of MARK2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for MARK2 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of MARK2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of MARK2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of MARK2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of MARK2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for MARK2 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MARK2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for MARK2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of MARK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of MARK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MARK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate MARK2 protein from the curated KEA Substrates of Kinases dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate MARK2 protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MARK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of MARK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with MARK2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MARK2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS Kinativ Kinase Inhibitor Bioactivity Profiles chemical bioactivity profiles with high inhibition of MARK2 kinase activity from the Kinativ Kinase Inhibitor Bioactivity Profiles dataset.
LINCS KinomeScan Kinase Inhibitor Targets small molecules inhibiting MARK2 kinase from the KinomeScan Kinase Inhibitor Targets dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of MARK2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of MARK2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LOCATE Curated Protein Localization Annotations cellular components containing MARK2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain MARK2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MARK2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting MARK2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MARK2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of MARK2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by MARK2 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of MARK2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of MARK2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
NURSA Protein Complexes protein complexs containing MARK2 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for MARK2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MARK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of MARK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving MARK2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving MARK2 protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with MARK2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate MARK2 protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving MARK2 protein from the PID Pathways dataset.
ProteomicsDB Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of MARK2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of MARK2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of MARK2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of MARK2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of MARK2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MARK2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of MARK2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of MARK2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with MARK2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of MARK2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs drug perturbations changing phosphorylation of MARK2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands ligand (protein) perturbations changing phosphorylation of MARK2 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with MARK2 gene from the SynGO Synaptic Gene Annotations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of MARK2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of MARK2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of MARK2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of MARK2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of MARK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of MARK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of MARK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of MARK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with MARK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with MARK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving MARK2 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving MARK2 protein from the WikiPathways Pathways 2024 dataset.